Jacobson & Schmitt Advisors’s Verona Pharma VRNA Stock Holding History

Jacobson & Schmitt Advisors’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-21,374	Closed	-$2.28M	–	84
2025 Q3	$2.28M	Sell	21,374 -16,297	-43%	-$1.7M	0.39%	41
2025 Q2	$3.56M	Sell	37,671 -32	-0.1%	-$2.37K	0.63%	38
2025 Q1	$2.39M	Sell	37,703 -6,045	-14%	-$362K	0.49%	41
2024 Q4	$2.03M	Buy	+43,748	New	+$1.64M	0.39%	42

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Jacobson & Schmitt Advisors's VRNA Position: Q4 2025 in Review

Jacobson & Schmitt Advisors sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 21,374 shares — an estimated $2.28M sold.

Jacobson & Schmitt Advisors first reported a position in VRNA in Q4 2024 and held it in 4 quarters. The position peaked at $3.56M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Jacobson & Schmitt Advisors reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Jacobson & Schmitt Advisors sold 21,374 Verona Pharma shares in Q4 2025, an estimated $2.28M.
Jacobson & Schmitt Advisors first reported a position in Verona Pharma in Q4 2024 and held it in 4 quarters.
Jacobson & Schmitt Advisors's Verona Pharma position peaked at $3.56M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Jacobson & Schmitt Advisors's 13F filing for Q4 2025, filed 21 Jan 2026.